Protons and ca2+: Ionic allies in tumor progression?

Physiology

Volumn 26, Issue 4, 2011, Pages 252-265

  Glitsch, Maike ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; G PROTEIN COUPLED RECEPTOR; HYDROGEN; ION CHANNEL; PROTON;

ANIMAL; CALCIUM SIGNALING; DISEASE COURSE; HUMAN; METABOLISM; NEOPLASM; PATHOLOGY; REVIEW;

ANIMALS; CALCIUM; CALCIUM SIGNALING; DISEASE PROGRESSION; HUMANS; HYDROGEN; ION CHANNELS; NEOPLASMS; PROTONS; RECEPTORS, G-PROTEIN-COUPLED;

EID: 80051612398     PISSN: 15489213     EISSN: 15489221     Source Type: Journal    
DOI: 10.1152/physiol.00005.2011     Document Type: Article

References (188)

1. Abdul M, Hoosein N. Reduced Kv1.3 potassium channel expression in human prostate cancer. J Membr Biol 214: 99-102, 2007.
2. Abdul M, Hoosein N. Voltage-gated potassium ion channels in colon cancer. Oncol Rep 9: 961-964, 2002.
3. Abdul M, Santo A, Hoosein N. Activity of potassium channelblockers in breast cancer. Anticancer Res 23: 3347-3351, 2003.
4. Amantini C, Mosca M, Nabissi M, Lucciarini R, Caprodossi S, Arcella A, Giangaspero F, Santoni G. Capsaicin-induced apoptosis of glioma cells is mediated by TRPV1 vanilloid receptor and requires p38 MAPK activation. J Neurochem 102: 977-990, 2007.
5. Anghileri LJ. Magnesium, calcium and cancer. Magnes Res 22: 247-255, 2009.
6. 2+ entry via non-selective cation channels. Cardiovasc Res 83: 97-105, 2009.
7. Barbado M, Fablet K, Ronjat M, De Waard M. Gene regulation by voltage-dependent calcium channels. Biochim Biophys Acta 1793: 1096, 2009.
8. +-gated channels in mouse sensory neurons. Proc Natl Acad Sci USA 99: 2338-2343, 2002.
9. Berdiev BK, Xia J, McLean LA, Markert JM, Gillespie GY, Mapstone TB, Naren AP, Jovov B, Bubien JK, Ji HL, Fuller CM, Kirk KL, Benos DJ. Acid-sensing ion channels in malignant gliomas. J Biol Chem 278: 15023-15034, 2003.
10. 2+-store in cancer. Anticancer Agents Med Chem 8: 705-709, 2008.
11. Bielanska J, Hernandez-Losa J, Perez-Verdaguer M, Moline T, Somoza R, Ramon YCS, Condom E, Ferreres JC, Felipe A. Voltage-dependent potassium channels Kv1.3 and Kv15 in human cancer. Curr Cancer Drug Targets 9: 904-914, 2009.
12. Bode AM, Cho YY, Zheng D, Zhu F, Ericson ME, Ma WY, Yao K, Dong Z. Transient receptor potential type vanilloid 1 suppresses skin carcinogenesis. Cancer Res 69: 905-913, 2009.
13. Bomben VC, Sontheimer H. Disruption of transient receptor potential canonical channel 1 causes incomplete cytokinesis and slows the growth of human malignant gliomas. Glia 58: 1145-1156, 2010.
14. Bubien JK, Ji HL, Gillespie GY, Fuller CM, Markert JM, Mapstone TB, Benos DJ. Cation selectivity and inhibition of malignant glioma Na_ channels by Psalmotoxin 1. Am J Physiol Cell Physiol 287: C1282-C1291, 2004.
15. Cai R, Ding X, Zhou K, Shi Y, Ge R, Ren G, Jin Y, Wang Y. Blockade of TRPC6 channels induced G2/M phase arrest and suppressed growth in human gastric cancer cells. Int J Cancer 125: 2281-2287, 2009.
16. Cairns R, Papandreou I, Denko N. Overcoming physiologic barriers to cancer treatment by molecularly targeting the tumor microenvironment. Mol Cancer Res 4: 61-70, 2006.
17. Caterina MJ, Schumacher MA, Tominaga M, Rosen TA, Levine JD, Julius D. The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature 389: 816-824, 1997.
18. + influx. Cell Calcium 47: 425-432, 2010.
19. Cheng H, Feng JM, Figueiredo ML, Zhang H, Nelson PL, Marigo V, Beck A. Transient receptor potential melastatin type 7 channel is critical for the survival of bone marrow derived mesenchymal stem cells. Stem Cells Dev 19: 1393-1403, 2010.
20. Chiche J, Brahimi-Horn MC, Pouyssegur J. Tumour hypoxia induces a metabolic shift causing acidosis: a common feature in cancer. J Cell Mol Med 14: 771-794, 2010.
21. Chinnadurai G, Vijayalingam S, Rashmi R. BIK, the founding member of the BH3-only family proteins: mechanisms of cell death and role in cancer and pathogenic processes. Oncogene 27: S20-29, 2008.
22. Choi JW, Herr DR, Noguchi K, Yung YC, Lee CW, Mutoh T, Lin ME, Teo ST, Park KE, Mosley AN, Chun J. LPA receptors: subtypes and biological actions. Ann Rev Pharmacol Toxicol 50: 157-186, 2010.
23. Contreras L, Drago I, Zampese E, Pozzan T. Mitochondria: the calcium connection. Biochim Biophys Acta 1797: 607-618, 2010.
24. Cotton M, Claing A. G protein-coupled receptors stimulation and the control of cell migration. Cell Signal 21: 1045-1053, 2009.
25. Coutinho-Silva R, Stahl L, Cheung KK, de Campos NE, de Oliveira Souza C, Ojcius DM, Burnstock G. P2X and P2Y purinergic receptors on human intestinal epithelial carcinoma cells: effects of extracellular nucleotides on apoptosis and cell proliferation. Am J Physiol Gastrointest Liver Physiol 288: G1024-G1035, 2005.
26. Czifra G, Varga A, Nyeste K, Marincsak R, Toth BI, Kovacs I, Kovacs L, Biro T. Increased expressions of cannabinoid receptor-1 and transient receptor potential vanilloid-1 in human prostate carcinoma. J Cancer Res Clin Oncol 135: 507-514, 2009.
27. DeBerardinis RJ, Sayed N, Ditsworth D, Thompson CB. Brick by brick: metabolism and tumor cell growth. Curr Opin Genet Dev 18: 54-61, 2008.
28. Delbro DS, Nylund G, Nordgren S. Demonstration of P2Y4 purinergic receptors in the HT-29 human colon cancer cell line. Auton Autacoid Pharmacol 25: 163-166, 2005.
29. Deval E, Gasull X, Noel J, Salinas M, Baron A, Diochot S, Lingueglia E. Acid-sensing ion channels (ASICs): pharmacology and implication in pain. Pharmacol Ther 128: 549-558, 2010.
30. Dhar MS, Plummer HK, 3rd. Protein expression of G-protein inwardly rectifying potassium channels (GIRK) in breast cancer cells. BMC Physiol 6: 8, 2006.
31. + oscillations through the spatial signature drives gene expression. Curr Biol 19: 853-858, 2009.
32. Ding X, He Z, Shi Y, Wang Q, Wang Y. Targeting TRPC6 channels in oesophageal carcinoma growth. Exp Opin Therap Targets 14: 513-527, 2010.
33. Ding X, He Z, Zhou K, Cheng J, Yao H, Lu D, Cai R, Jin Y, Dong B, Xu Y, Wang Y. Essential role of TRPC6 channels in G2/M phase transition and development of human glioma. J Natl Cancer Inst 102: 1052-1068, 2010.
34. Dolmetsch RE, Xu K, Lewis RS. Calcium oscillations increase the efficiency and specificity of gene expression. Nature 392: 933-936, 1998.
35. Eid SR, Cortright DN. Transient receptor potential channels on sensory nerves. Handb Exp Pharmacol: 261-281, 2009.
36. Fang JS, Gillies RD, Gatenby RA. Adaptation to hypoxia and acidosis in carcinogenesis and tumor progression. Seminars Cancer Biol 18: 330-337, 2008.
37. Feske S, Giltnane J, Dolmetsch R, Staudt LM, Rao A. Gene regulation mediated by calcium signals in T lymphocytes. Nat Immunol 2: 316-324, 2001.
38. 2+-nucleotide-regulated channel-kinase TRPM7. In: Transient Receptor Potential (TRP) Channels. Berlin: Springer Berlin Heidelberg, 2007, p. 313.
39. Francesco DV, Baricordi Roberto O, Romeo R, Pier Giovanni, B. Leukocyte P2 receptors: a novel target for anti-inflammatory and antitumor therapy. Curr Drug Targets Cardiovas Hematological Disorders 5: 85, 2005.
40. Fraser SP, Grimes JA, Diss JK, Stewart D, Dolly JO, Djamgoz MB. Predominant expression of Kv1.3 voltage-gated K_ channel subunit in rat prostate cancer cell lines: electrophysiological, pharmacological and molecular characterization. Pflügers Arch 446: 559-571, 2003.
41. Fukumura D, Jain RK. Imaging angiogenesis and the microenvironment. APMIS 116: 695-715, 2008.
42. Fukumura D, Jain RK. Tumor microenvironment abnormalities: causes, consequences, and strategies to normalize. J Cell Biochem 101: 937-949, 2007.
43. Furusato B, Mohamed A, Uhlén M, Rhim JS. CXCR4 and cancer. Pathol Int 60: 497-505, 2010.
44. Gatenby RA, Gillies RJ. Why do cancers have high aerobic glycolysis? Nat Rev Cancer 4: 891, 2004.
45. 2+ signaling. Cold Spring Harb Prospect Biol 2: a003962, 2010.
46. Gende OA. Capacitative calcium influx and intracellular pH cross-talk in human platelets. Platelets 14: 9-14, 2003.
47. Gerevich Z, Zadori ZS, Kãles L, Kopp L, Milius D, Wirkner K, Gyires K, Illes P. Dual effect of acid pH on purinergic P2X3 receptors depends on the histidine 206 residue. J Biol Chem 282: 33949-33957, 2007.
48. Ghilardi JR, Rohrich H, Lindsay TH, Sevcik MA, Schwei MJ, Kubota K, Halvorson KG, Poblete J, Chaplan SR, Dubin AE, Carruthers NI, Swanson D, Kuskowski M, Flores CM, Julius D, Mantyh PW. Selective blockade of the capsaicin receptor TRPV1 attenuates bone cancer pain. J Neurosci 25: 3126-3131, 2005.
49. Ghosh AK, Basu S. Fas-associated factor 1 is a negative regulator in capsaicin induced cancer cell apoptosis. Cancer Lett 287: 142-149, 2009.
50. Gillies R, Gatenby R. Hypoxia and adaptive landscapes in the evolution of carcinogenesis. Cancer Metastasis Rev 26: 311-317, 2007.
51. Gillies RJ, Raghunand N, Karczmar GS, Bhujwalla ZM. MRI of the tumor microenvironment. J Magn Reson Imaging 16: 430-450, 2002.
52. Glitsch MD. Activation of native TRPC3 cation channels by phospholipase D. FASEB J 24: 318-325, 2009.
53. Gogvadze V, Orrenius S, Zhivotovsky B. Mitochondria as targets for cancer chemotherapy. Semin Cancer Biol 19: 57-66, 2009.
54. Gonzalez-Rodriguez S, Pevida M, Roques BP, Fournie-Zaluski MC, Hidalgo A, Menendez L, Baamonde A. Involvement of enkephalins in the inhibition of osteosarcoma-induced thermal hyperalgesia evoked by the blockade of peripheral P2X3 receptors. Neurosci Lett 465: 285-289, 2009.
55. Gozuacik D, Kimchi A. Autophagy as a cell death and tumor suppressor mechanism. Oncogene 23: 2891-2906, 2004.
56. Guilbert A, Gautier M, Dhennin-Duthille I, Haren N, Sevestre H, Ouadid-Ahidouch H. Evidence that TRPM7 is required for breast cancer cell proliferation. Am J Physiol Cell Physiol 297: C493-C502, 2009.
57. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 100: 57, 2000.
58. + channels. Proc Natl Acad Sci USA 103: 2886-2891, 2006.
59. Helmlinger G, Sckell A, Dellian M, Forbes NS, Jain RK. Acid production in glycolysis-impaired tumors provides new insights into tumor metabolism. Clinic Cancer Res 8: 1284-1291, 2002.
60. Hemmerlein B, Weseloh RM, Mello de Queiroz F, Knotgen H, Sanchez A, Rubio ME, Martin S, Schliephacke T, Jenke M, Heinz Joachim R, Stuhmer W, Pardo LA. Overexpression of Eag1 potassium channels in clinical tumours. Mol Cancer 5: 41, 2006.
61. Holmuhamedov E, Lewis L, Bienengraeber M, Holmuhamedova M, Jahangir A, Terzic A. Suppression of human tumor cell proliferation through mitochondrial targeting. FASEB J 16: 1010-1016, 2002.
62. Holzer P. Acid-sensitive ion channels and receptors. Handbook Exp Pharmacol: 283-332, 2009.
63. Holzer P. Acid sensing by visceral afferent neurones. Acta Physiol 201: 63-75, 2011.
64. 2+ signaling and ERK phosphorylation in granule precursor tumour cells. Cell Calcium 45: 391-399, 2009.
65. 2+ signals. Curr Biol 18: 781-785, 2008.
66. Huang WC, Young JS, Glitsch MD. Changes in TRPC channel expression during postnatal development of cerebellar neurons. Cell Calcium 42: 1-10, 2007.
67. Hwang MK, Bode AM, Byun S, Song NR, Lee HJ, Lee KW, Dong Z. Cocarcinogenic effect of capsaicin involves activation of EGFR signaling but not TRPV1. Cancer Res 70: 6859-6869, 2010.
68. Ishiguro T, Avila H, Lin SY, Nakamura T, Yamamoto M, Boyd DD. Gene trapping identifies chloride channel 4 as a novel inducer of colon cancer cell migration, invasion and metastases. Br J Cancer 102: 774-782, 2010.
69. Izumi H, Torigoe T, Ishiguchi H, Uramoto H, Yoshida Y, Tanabe M, Ise T, Murakami T, Yoshida T, Nomoto M, Kohno K. Cellular pH regulators: potentially promising molecular targets for cancer chemotherapy. Cancer Treat Rev 29: 541-549, 2003.
70. Jaffe LF. A calcium-based theory of carcinogenesis. Adv Cancer Res 94: 231-263, 2005.
71. Jang SH, Choi SY, Ryu PD, Lee SY. Antiproliferative effect of Kv1.3 blockers in A549 human lung adenocarcinoma in vitro and in vivo. Eur J Pharmacol 651: 26-32, 2010.
72. + channel subunit as a potential diagnostic marker and therapeutic target for breast cancer. BMB Rep 42: 535-539, 2009.
73. Jiang J, Li MH, Inoue K, Chu XP, Seeds J, Xiong ZG. Transient receptor potential melastatin 7-like current in human head and neck carcinoma cells: role in cell proliferation. Cancer Res 67: 10929-10938, 2007.
74. Jiang J, Li M, Yue L. Potentiation of TRPM7 inward currents by protons. J Gen Physiol 126: 137-150, 2005.
75. 2+ homeostasis. Science 322: 756-760, 2008.
76. Jordt SE, Tominaga M, Julius D. Acid potentiation of the capsaicin receptor determined by a key extracellular site. Proc Natl Acad Sci USA 97: 8134-8139, 2000.
77. Kaan TK, Yip PK, Patel S, Davies M, Marchand F, Cockayne DA, Nunn PA, Dickenson AH, Ford AP, Zhong Y, Malcangio M, McMahon SB. Systemic blockade of P2X3 and P2X2/3 receptors attenuates bone cancer pain behaviour in rats. Brain 133: 2549-2564, 2010.
78. Kahl CR, Means AR. Regulation of cell cycle progression by calcium/calmodulin-dependent pathways. Endocr Rev 24: 719-736, 2003.
79. Kalogris C, Caprodossi S, Amantini C, Lambertucci F, Nabissi M, Morelli MB, Farfariello V, Filosa A, Emiliozzi MC, Mammana G, Santoni G. Expression of transient receptor potential vanilloid-1 (TRPV1) in urothelial cancers of human bladder: relation to clinicopathological and molecular parameters. Histopathology 57: 744-752, 2010.
80. Kang SS, Han KS, Ku BM, Lee YK, Hong J, Shin HY, Almonte AG, Woo DH, Brat DJ, Hwang EM, Yoo SH, Chung CK, Park SH, Paek SH, Roh EJ, Lee Sj Park JY, Traynelis SF, Lee CJ. Caffeinemediated inhibition of calcium release channel inositol 1,4,5-trisphosphate receptor subtype 3 blocks glioblastoma invasion and extends survival. Cancer Res 70: 1173-1183, 2010.
81. Kapoor N, Bartoszewski R, Qadri YJ, Bebok Z, Bubien JK, Fuller CM, Benos DJ. Knockdown of ASIC1 and epithelial sodium channel subunits inhibits glioblastoma whole cell current and cell migration. J Biol Chem 284: 24526-24541, 2009.
82. Kawamata T, Niiyama Y, Yamamoto J, Furuse S. Reduction of bone cancer pain by CB1 activation and TRPV1 inhibition. J Anesth 24: 328-332, 2010.
83. Kim BJ, Park EJ, Lee JH, Jeon JH, Kim SJ, So I. Suppression of transient receptor potential melastatin 7 channel induces cell death in gastric cancer. Cancer Sci 99: 2502-2509, 2008.
84. Kiselyov K, Soyombo A, Muallem S. TRPpathies. J Physiol 578: 641-653, 2007.
85. + handling in lysosomal storage disorders. Cell Calcium 47: 103-111, 2010.
86. Kunzelmann K. Ion channels and cancer. J Mem Biology 205: 159-173, 2005.
87. Lazzeri M, Vannucchi MG, Spinelli M, Bizzoco E, Beneforti P, Turini D, Faussone-Pellegrini MS. Transient receptor potential vanilloid type 1 (TRPV1) expression changes from normal urothelium to transitional cell carcinoma of human bladder. Eur Urol 48: 691-698, 2005.
88. Lee HJ, Wall B, Chen S. G-protein-coupled receptors and melanoma. Pigment Cell Melanoma Res 21: 415-428, 2008.
89. Li H, Wang D, Singh LS, Berk M, Tan H, Zhao Z, Steinmetz R, Kirmani K, Wei G, Xu Y. Abnormalities in osteoclastogenesis and decreased tumorigenesis in mice deficient for ovarian cancer G protein-coupled receptor 1. PLoS One 4: e5705, 2009.
90. Li S, Huang S, Peng SB. Overexpression of G protein-coupled receptors in cancer cells: involvement in tumor progression. Int J Oncol 27: 1329-1339, 2005.
91. Lin ME, Herr DR, Chun J. Lysophosphatidic acid (LPA) receptors: signaling properties and disease relevance. Prostaglandin Other Lipid Mediat 91: 130-138, 2010
92. Lingueglia E. Acid-sensing ion channels in sensory perception. J Biol Chem 282: 17325-17329, 2007.
93. Lipskaia L, Hulot JS, Lompré AM. Role of sarco/ endoplasmic reticulum calcium content and calcium ATPase activity in the control of cell growth and proliferation. Pflügers Arch 457: 673-685, 2009.
94. Ludwig MG, Vanek M, Guerini D, Gasser JA, Jones CE, Junker U, Hofstetter H, Wolf RM, Seuwen K. Proton-sensing G-protein-coupled receptors. Nature 425: 93-98, 2003.
95. Mackrill JJ. Ryanodine receptor calcium channels and their partners as drug targets. Biochem Pharmacol 79: 1535-1543, 2010.
96. Malagarie-Cazenave S, Olea-Herrero N, Vara D, Diaz-Laviada I. Capsaicin, a component of red peppers, induces expression of androgen receptor via PI3K and MAPK pathways in prostate LNCaP cells. FEBS Lett 583: 141-147, 2009.
97. Malhotra JD, Kazen-Gillespie K, Hortsch M, Isom LL. Sodium channel β subunits mediate homophilic cell adhesion and recruit ankyrin to points of cell-Cell contact. J Biol Chem 275: 11383-11388, 2000.
98. Mantyh PW, Clohisy DR, Koltzenburg M, Hunt SP. Molecular mechanisms of cancer pain. Nat Rev Cancer 2: 201-209, 2002.
99. + (GIRK) channels by extracellular acidosis. J Biol Chem 277: 46166-46171, 2002.
100. Marín YE, Chen S. Involvement of metabotropic glutamate receptor 1, a G protein coupled receptor, in melanoma development. J Mol Med 82: 735-749, 2004.
101. McCarron JG, Chalmers S, Bradley KN, Mac-Millan D, Muir TC. Ca2+ microdomains in smooth muscle. Cell Calcium 40: 461-493, 2006.
102. McKay RR, Szymeczek-Seay CL, Lievremont JP, Bird GS, Zitt C, Jungling E, Luckhoff A, Putney JW, Jr. Cloning and expression of the human transient receptor potential 4 (TRP4) gene: localization and functional expression of human TRP4 and TRP3. Biochem J 351: 735-746, 2000.
103. Mekhail K, Khacho M, Gunaratnam L, Lee S. Oxygen sensing by H_: implications for HIF and hypoxic cell memory. Cell Cycle 3: 1027-1029, 2004.
104. Menéndez L, Juárez L, García E, García-Suárez O, Hidalgo A, Baamonde A. Analgesic effects of capsazepine and resiniferatoxin on bone cancer pain in mice. Neurosci Letters 393: 70-73, 2006.
105. Miao X, Liu G, Xu X, Xie C, Sun F, Yang Y, Zhang T, Hua S, Fan W, Li Q, Huang S, Wang Q, Liu G, Zhong D. High expression of vanilloid receptor-1 is associated with better prognosis of patients with hepatocellular carcinoma. Cancer Genet Cytogenet 186: 25-32, 2008.
106. + stores. Curr Opin Cell Biol 17: 135, 2005.
107. +/calmodulinsensitive TRPM7-like current in hepatoma and hepatocytes. Am J Physiol Gastrointest Liver Physiol 297: G687-G694, 2009.
108. Moellering RE, Black KC, Krishnamurty C, Baggett BK, Stafford P, Rain M, Gatenby RA, Gillies RJ. Acid treatment of melanoma cells selects for invasive phenotypes. Clin Exp Metastasis 25: 411-425, 2008.
109. Monet Ml, Lehen'kyi Vy Gackiere F, Firlej V, Vandenberghe M, Roudbaraki M, Gkika D, Pourtier A, Bidaux G, Slomianny C, Delcourt P, Rassendren Fo Bergerat JP, Ceraline J, Cabon F, Humez S, Prevarskaya N. Role of cationic channel TRPV2 in promoting prostate cancer migration and progression to androgen resistance. Cancer Res 70: 1225-1235, 2010.
110. + transport. Nat Rev Cancer 7: 519-530, 2007.
111. Motiani RK, Abdullaev IF, Trebak M. A novel native store-operated calcium channel encoded by Orai3: selective requirement of Orai3 versus Orai1 in estrogen receptor-positive versus estrogen receptor-negative breast cancer cells. J Biol Chem 285: 19173-19183, 2010.
112. + entry: a way to control cell proliferation. Curr Med Chem 11: 1533-1543, 2004.
113. Newell K, Franchi A, Pouysségur J, Tannock I. Studies with glycolysis-deficient cells suggest that production of lactic acid is not the only cause of tumor acidity. Proc Natl Acad of Sci USA 90: 1127-1131, 1993.
114. Niiyama Y, Kawamata T, Yamamoto J, Furuse S, Namiki A. SB366791, a TRPV1 antagonist, potentiates analgesic effects of systemic morphine in a murine model of bone cancer pain. Br J Anaesth 102: 251-258, 2009.
115. Niiyama Y, Kawamata T, Yamamoto J, Omote K, Namiki A. Bone cancer increases transient receptor potential vanilloid subfamily 1 expression within distinct subpopulations of dorsal root ganglion neurons. Neuroscience 148: 560-572, 2007.
116. Nylund G, Hultman L, Nordgren S, Delbro DS. P2Y2-and P2Y4 purinergic receptors are overexpressed in human colon cancer. Auton Autacoid Pharmacol 27: 79-84, 2007.
117. Panner A, Wurster RD. T-type calcium channels and tumor proliferation. Cell Calcium 40: 253-259, 2006.
118. Pardo LA, Stuhmer W. Eag1: an emerging oncological target. Cancer Res 68: 1611-1613, 2008.
119. + oscillations. Trends Biochem Sci 36: 78-87, 2010.
120. Pathak R, Bhatnagar S, Dubey AK. Mechanisms underlying the opposing effects of P2Y receptors on the cell cycle. J Recept Signal Transduct Res 28: 505-529, 2008.
121. Peng JB, Chen XZ, Berger UV, Vassilev PM, Brown EM, Hediger MA. A rat kidney-specific calcium transporter in the distal nephron. J Biol Chem 275: 28186-28194, 2000.
122. +-induced pancreatic cell death: roles of the endoplasmic reticulum, zymogen granules, lysosomes and endosomes. J Gastroenterol Hepatol 23: S31-S38, 2008.
123. Plummer HK, 3rd Dhar MS, Cekanova M, Schuller HM. Expression of G-protein inwardly rectifying potassium channels (GIRKs) in lung cancer cell lines. BMC Cancer 5: 104, 2005.
124. Plummer HK, 3rd Yu Q, Cakir Y, Schuller HM. Expression of inwardly rectifying potassium channels (GIRKs) and beta-adrenergic regulation of breast cancer cell lines. BMC Cancer 4: 93, 2004.
125. Poirot O, Vukicevic M, Boesch A, Kellenberger S. Selective regulation of acid-sensing ion channel 1 by serine proteases. J Biol Chem 279: 38448-38457, 2004.
126. Preussat K, Beetz C, Schrey M, Kraft R, Wolfl S, Kalff R, Patt S. Expression of voltage-gated potassium channels Kv1.3 and Kv1.5 in human gliomas. Neurosci Lett 346: 33-36, 2003.
127. Pua TL, Wang Fq, Fishman DA. Roles of LPA in ovarian cancer development and progression. Future Oncology 5: 1659-1673, 2009.
128. +-sensing receptor, CaR. Pflügers Arch 458: 1007-1022, 2009.
129. Robey IF, Baggett BK, Kirkpatrick ND, Roe DJ, Dosescu J, Sloane BF, Hashim AI, Morse DL, Raghunand N, Gatenby RA, Gillies RJ. Bicarbonate increases tumor pH and inhibits spontaneous metastases. Cancer Res 69: 2260-2268, 2009.
130. + for cancer cell proliferation and survival. Nat Rev Cancer 8: 361-375, 2008.
131. Rong Y, Distelhorst CW. Bcl-2 protein family members: versatile regulators of calcium signaling in cell survival and apoptosis. Annu Rev Physiol 70: 73-91, 2008.
132. + channels contribute to regulatory volume increases in human glioma cells. Am J Physiol Cell Physiol 293: C1181-C1185, 2007.
133. + homeostasis in mammals. Nat Commun 1: 109, 2010.
134. Saidak Z, Mentaverri R, Brown EM. The role of the calcium-sensing receptor in the development and progression of cancer. Endocr Rev 30: 178-195, 2009.
135. + entry. Cell Calcium 45: 319-325, 2009.
136. Sanchez MG, Sanchez AM, Collado B, Malagarie-Cazenave S, Olea N, Carmena MJ, Prieto JC, Diaz-Laviada II. Expression of the transient receptor potential vanilloid 1 (TRPV1) in LNCaP and PC-3 prostate cancer cells and in human prostate tissue. Eur J Pharmacol 515: 20-27, 2005.
137. Sandoz G, Douguet D, Chatelain F, Lazdunski M, Lesage F. Extracellular acidification exerts opposite actions on TREK1 and TREK2 potassium channels via a single conserved histidine residue. Proc Natl Acad Sci USA 106: 14628-14633, 2009.
138. Semtner M, Schaefer M, Pinkenburg O, Plant TD. Potentiation of TRPC5 by protons. J Biol Chem 282: 33868-33878, 2007.
139. Seuwen K, Ludwig MG, Wolf RM. Receptors for protons or lipid messengers or both? J Recept Signal Transduct Res 26: 599-610, 2006.
140. Shi Y, Ding X, He ZH, Zhou KC, Wang Q, Wang YZ. Critical role of TRPC6 channels in G2 phase transition and the development of human oesophageal cancer. Gut 58: 1443-1450, 2009.
141. Shin HY, Hong YH, Jang SS, Chae HG, Paek SL, Moon HE, Kim DG, Kim J, Paek SH, Kim SJ. A role of canonical transient receptor potential 5 channel in neuronal differentiation from A2B5 neural progenitor cells. PLoS Biol 5: e10359, 2010.
142. Shin SS, Martino JJ, Chen S. Metabotropic glutamate receptors (mGlus) and cellular transformation. Neuropharmacol 55: 396, 2008.
143. Singh LS, Berk M, Oates R, Zhao Z, Tan H, Jiang Y, Zhou A, Kirmani K, Steinmetz R, Lindner D, Xu Y. Ovarian cancer G protein-coupled receptor 1, a new metastasis suppressor gene in prostate cancer. J Natl Cancer Inst 99: 1313-1327, 2007.
144. Somodi S, Varga Z, Hajdu P, Starkus JG, Levy DI, Gaspar R, Panyi G. pH-dependent modulation of Kv1.3 inactivation: role of His399. Am J Physiol Cell Physiol 287: C1067-C1076, 2004.
145. Somodi S, Varga Z, Hajdu P, Starkus JG, Levy DI, Gaspar R, Panyi G. pH-dependent modulation of Kv1.3 inactivation: role of His399. Am J Physiol Cell Physiol 287: C1067-C1076, 2004.
146. Sontheimer H. Ion channels and amino acid transporters support the growth and invasion of primary brain tumors. Molec Neurobiol 29: 61-71, 2004.
147. Stagg J, Smyth MJ. Extracellular adenosine triphosphate and adenosine in cancer. Oncogene 29: 5346-5358, 2010.
148. Steidl JV, Yool AJ. Differential sensitivity of voltage-gated potassium channels Kv1.5 and Kv12 to acidic pH and molecular identification of pH sensor. Molec Pharmacol 55: 812-820, 1999.
149. Stock C, Schwab A. Protons make tumor cells move like clockwork. Pflügers Arch 458: 981-992, 2009.
150. Stoop R, Surprenant A, North RA. Different sensitivities to pH of ATP-induced currents at four cloned P2X receptors. J Neurophysiol 78: 1837-1840, 1997.
151. Stoop R, Surprenant A, North RA. Different sensitivities to pH of ATP-induced currents at four cloned P2X receptors. J Neurophysiol 78: 1837-1840, 1997.
152. Suh BC, Hille B. PIP2 is a necessary cofactor for ion channel function: how and why? Annu Rev Biophys 37: 175-195, 2008.
153. Sung TS, Kim MJ, Hong S, Jeon JP, Kim BJ, Jeon JH, Kim SJ, So I. Functional characteristics of TRPC4 channels expressed in HEK 293 cells. Mol Cells 27: 167-173, 2009.
154. Suzuki M, Mizuno A, Kodaira K, Imai M. Impaired pressure sensation in mice lacking TRPV4. J Biol Chem 278: 22664-22668, 2003.
155. Swietach P, Vaughan-Jones R, Harris A. Regulation of tumor pH and the role of carbonic anhydrase 9. Cancer Metastasis Rev 26: 299-310, 2007.
156. Takanami I, Inoue Y, Gika M. G-protein inwardly rectifying potassium channel 1 (GIRK 1) gene expression correlates with tumor progression in non-small cell lung cancer. BMC Cancer 4: 79, 2004.
157. Talavera K, Nilius B. Biophysics and structurefunction relationship of T-type Ca2_ channels. Cell Calcium 40: 97-114, 2006.
158. Tannock IF, Rotin D. Acid pH in tumors and its potential for therapeutic exploitation. Cancer Res 49: 4373-4384, 1989.
159. Teicher BA, Fricker SP. CXCL12 (SDF-1)/CXCR4 pathway in cancer. Clin Cancer Res 16: 2927-2931, 2010.
160. 2+ regulates activation of rat eag potassium channel. Pflügers Arch 432: 301-312, 1996.
161. 2+ entry and proliferation of prostate cancer epithelial cells. Cancer Res 66: 2038-2047, 2006.
162. Toffoli S, Michiels C. Intermittent hypoxia is a key regulator of cancer cell and endothelial cell interplay in tumours. FEBS J 275: 2991-3002, 2008.
163. Tominaga M, Caterina MJ, Malmberg AB, Rosen TA, Gilbert H, Skinner K, Raumann BE, Basbaum AI, Julius D. The cloned capsaicin receptor integrates multiple pain-producing stimuli. Neuron 21: 531-543, 1998.
164. Tong Z, Luo W, Wang Y, Yang F, Han Y, Li H, Luo H, Duan B, Xu T, Maoying Q, Tan H, Wang J, Zhao H, Liu F, Wan Y. Tumor tissue-derived formaldehyde and acidic microenvironment synergistically induce bone cancer pain. PLoS Biol 5: e10234, 2010.
165. Trebak M, Lemonnier L, Smyth JT, Vazquez G, Putney JW, Jr. Phospholipase C-coupled receptors and activation of TRPC channels. Handbook Exp Pharmacol: 593-614, 2007.
166. 2+ channels in prostate cancer epithelial cells: function, regulation, and role in carcinogenesis. Cell Calcium 33: 357-373, 2003.
167. Veliceasa D, Ivanovic M, Hoepfner FT, Thumbikat P, Volpert OV, Smith ND. Transient potential receptor channel 4 controls thrombospondin-1 secretion and angiogenesis in renal cell carcinoma. FEBS J 274: 6365-6377, 2007.
168. Venkatachalam K, Montell C. TRP channels. Annu Rev Biochem 76: 387-417, 2007.
169. Vila-Carriles WH, Kovacs GG, Jovov B, Zhou ZH, Pahwa AK, Colby G, Esimai O, Gillespie GY, Mapstone TB, Markert JM, Fuller CM, Bubien JK, Benos DJ. Surface expression of ASIC2 inhibits the amiloride-sensitive current and migration of glioma cells. J Biol Chem 281: 19220-19232, 2006.
170. Vriens J, Appendino G, Nilius B. Pharmacology of vanilloid transient receptor potential cation channels. Molec Pharmacol 75: 1262-1279, 2009.
171. Wagner V, Stadelmeyer E, Riederer M, Regitnig P, Gorischek A, Devaney T, Schmidt K, Tritthart HA, Hirschberg K, Bauernhofer T, Schreibmayer W. Cloning and characterisation of GIRK1 variants resulting from alternative RNA editing of the KCNJ3 gene transcript in a human breast cancer cell line. J Cell Biochem 110: 598-608, 2010.
172. Waldmann R, Bassilana F, de Weille J, Champigny G, Heurteaux C, Lazdunski M. Molecular cloning of a non-inactivating protongated Na_ channel specific for sensory neurons. J Biol Chem 272: 20975-20978, 1997.
173. Waldmann R, Champigny G, Bassilana F, Heurteaux C, Lazdunski M. A proton-gated cation channel involved in acid-sensing. Nature 386: 173-177, 1997.
174. Wang G, Yang ZQ, Zhang K. Endoplasmic reticulum stress response in cancer: molecular mechanism and therapeutic potential. Am J Transl Res 2: 65-74, 2010.
175. Wang JQ, Kon J, Mogi C, Tobo M, Damirin A, Sato K, Komachi M, Malchinkhuu E, Murata N, Kimura T, Kuwabara A, Wakamatsu K, Koizumi H, Uede T, Tsujimoto G, Kurose H, Sato T, Harada A, Misawa N, Tomura H, Okajima F. TDAG8 is a proton-sensing and psychosine-sensitive Gprotein-coupled receptor. J Biol Chem 279: 45626-45633, 2004.
176. 2+ ions. Br J Pharmacol 140: 1177-1186, 2003.
177. Wirkner K, Sperlagh B, Illes P. P2X3 receptor involvement in pain states. Mol Neurobiol 36: 165-183, 2007.
178. Wolf FI, Maier JAM, Nasulewicz A, Feillet-Coudray C, Simonacci M, Mazur A, Cittadini A. Magnesium and neoplasia: from carcinogenesis to tumor growth and progression or treatment. Arch Biochem Biophys 458: 24-32, 2007.
179. Wulff H, Castle NA, Pardo LA. Voltage-gated potassium channels as therapeutic targets. Nat Rev Drug Discov 8: 982-1001, 2009.
180. Xu Y, Casey G. Identification of human OGR1, a novel G protein-coupled receptor that maps to chromosome 14. Genomics 35: 397-402, 1996.
181. Yagi J, Wenk HN, Naves LA, McCleskey EW. Sustained currents through ASIC3 ion channels at the modest pH changes that occur during myocardial ischemia. Circ Res 99: 501-509, 2006.
182. Yamagata M, Hasuda K, Stamato T, Tannock IF. The contribution of lactic acid to acidification of tumours: studies of variant cells lacking lactate dehydrogenase. Br J Cancer 77: 1726-1731, 1998.
183. Yang S, Zhang JJ, Huang XY. Orai1 and STIM1 are critical for breast tumor cell migration and metastasis. Cancer Cell 15: 124-134, 2009.
184. Ye JH, Gao J, Wu YN, Hu YJ, Zhang CP, Xu TL. Identification of acid-sensing ion channels in adenoid cystic carcinomas. Biochem Biophys Res Commun 355: 986-992, 2007.
185. 2+-sensitive Socs3a signaling in development and cancer. Dis Model Mech 4: 240-254, 2011.
186. Yoneda T, Hata K, Nakanishi M, Nagae M, Nagayama T, Wakabayashi H, Nishisho T, Sakurai T, Hiraga T. Involvement of acidic microenvironment in the pathophysiology of cancer-associated bone pain. Bone 48: 100-105, 2011.
187. Zhang P, Canessa CM. Single channel properties of rat acid-sensitive ion channel-1alpha, -2a, and -3 expressed in Xenopus oocytes. J Gen Physiol 120: 553-566, 2002.
188. Ziglioli F, Frattini A, Maestroni U, Dinale F, Ciufifeda M, Cortellini P. Vanilloid-mediated apoptosis in prostate cancer cells through a TRPV-1 dependent and a TRPV-1-independent mechanism. Acta Biomed Ateneo Parmense 80: 13-20, 2009.